To study the role of probiotics in the prevention of necrotizing enterocolitis in preterm neonates
Keywords:Mortality, NEC, Probiotics, Sepsis
Background: Necrotizing enterocolitis is defined as an inflammatory bowel necrosis in premature infants and is major cause of morbidity and mortality in neonatal intensive care units throughout the world. We aim to study the role of probiotics in reducing incidence and severity of necrotizing enterocolitis in preterm neonates ≤34 weeks and its role on secondary outcomes like mortality, time to reach full feeds, daily weight gain, days of hospitalization and effect on nosocomial infections.
Methods: This study was a prospective randomized controlled interventional trial conducted in SGRDIMSAR, Amritsar. A sample size of 150 was selected. 75 were randomized to test group and 75 to control group by simple random sampling.
Results: The incidence of NEC was significantly lower in the test group compared with the control group (1 of 75 neonates vs 12 of 75 neonates; p=0.001). The severity of NEC, nosocomial sepsis and mean duration of hospital stay was significantly lower in the test group. Daily weight gain was significantly higher in the test group. There was no significant difference in mean age of onset of NEC, mortality and mean age to reach full feeds in two groups.
Conclusions: Incidence and severity of NEC was less in the probiotic group. Daily weight gain was better, nosocomial sepsis and mean duration of hospital stay were less in the probiotic group.
Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: Pathogenesis, prevention and management. Drugs. 2008;68(9):1227-38.
Neu J, Walker WA. Necrotizing enterocolitis.N Engl J Med. 2011;364(3):255-64.
Kosloske AM. Epidemiology of necrotising enterocolitis. Acta Paediatrica. 1994;83(396):2-7.
Newell SJ. Gastrointestinal disorders: Necrotising enterocolitis. In: Rennie JM, Roberton NRC, eds. Textbook of Neonatology, 3rd edition, Churchill Livingstone. 1999:747-55.
Narang A, Rao R, Bhakoo ON. Neonatal necrotizing enterocolitis an epidemiological study. Indian Pediatr. 1993;30:1207-14.
Neu J, Mshvildadze M, Mai V. A roadmap for understanding and preventing necrotizing enterocolitis. Curr Gastroenterol Rep. 2008;10(5):450-7.
Neu J, Douglas-Escobar M, Lopez M. Microbes and the developing gastrointestinal tract. Nutr Clin Pract. 2007;22(2):174-82.
Schanler RJ. Probiotics and necrotising enterocolitis in premature infants. Arch Dis Childhood Fetal Neonatal Edition. 2006;91(6):395-7.
Rabinowitz S, Dzakpasu P, Piecuch S, Leblanc P, Valencia G, Kornecki E. Platelet activating factor in infants at risk for necrotizing enterocolitis. J Pediatr. 2001;138(1):81-6.
Caplan MS, Hedlund E, Adler L, Lickerman M, Hsueh W. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr. 1997;24(3):296-301.
Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA. 2000;97(11):6043-8.
Bin-Nun A, Bromiker R, Wilschanski M. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147:192-6.
Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82(2):103-8.
Lin HC, Su BH, Chen AC. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115:1-4.
Sreenivasa B, Sunil Kumar P, Suresh Babu MT, Ragavendra K. Role of synbiotics in the prevention of necrotizing enterocolitis in preterm neonates: a randomized controlled trial. Int J Contemp Pediatr. 2015;2(2):127-30.
Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics. 2012;130(5):1113-20.
Härtel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr. 2014;165(2):285-9.
Sonawane R, Patil S, Godbole T, Pande S, Tolani MK. Role of Synbiotics in Improvement of Feed Tolerance and Weight Gain in the Newborns. MVP J Med Sci. 2014;1(2):61-6.
Chowdhury T, Ali MM, Hossain MM, Singh J, Yousuf AN, Yasmin F, et al. Efficacy of probiotics versus placebo in the prevention of necrotizing enterocolitis in preterm very low birth weight infants: a double-blind randomized controlled trial. J Coll Physicians Surgeons Pak. 2016;26(9):770-4.
Samanta M, Sarkar M, Ghosh P, Ghosh Jk, Sinha Mk, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr. 2009;55(2):128-31.